A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...
Tirzepatide may be more effective than semaglutide or liraglutide for weight loss, as it has a dual mechanism of action.
A long-term study reveals how tirzepatide not only cuts weight but also slashes diabetes risk in people with prediabetes, highlighting a major advance in obesity and diabetes care. In a phase-3 ...
On March 5, 2025, the U.S. District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a ...
Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...
The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...